Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute
Interventions: Busulfan, Melphalan, Fludarabine, CD34+ Allogeneic Peripheral Blood Stem Cell Transplant; Drug · Procedure
Lead sponsor: Guenther Koehne; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2034
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Vesico-Ureteral Reflux
Interventions: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 6 Months to 35 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy Aging, Cognitive Benefits, Cardio Respiratory Fitness, Brain Activity
Interventions: High-Intensity Interval Training; Behavioral
Lead sponsor: Colby-Sawyer College; Other
Eligibility: 55 Years to 79 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New London, New Hampshire

Conditions: Obesity and Obesity-related Medical Conditions
Interventions: Lifestyle Coaching; Behavioral
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Sommerville, Massachusetts

Conditions: Sickle Cell Disease, Sickle Cell Anemia in Children, Sickle Cell Disease (SCD), Sickle Cell, Sickle Cell Anemia (HbSS)
Interventions: Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session; Behavioral · Other
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Diabetic Retinopathy (DR), Macular Edema (ME)
Interventions: Animated Videos; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Pain
Interventions: Mindfulness of Breath Practice (15 min), Sham-Mindfulness Practice; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Cognitive Decline
Interventions: Resveratrol, Quercetin, and Curcumin (RQC), Curcumin; Drug
Lead sponsor: Zaparackas and Knepper LTD; Other
Eligibility: 50 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pheochromocytoma, Paraganglioma
Interventions: Zanzalintinib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Opioid Use Disorder
Interventions: Buprenorphine, Oxycodone; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 80 Years
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Cancer-related Fatigue, Neuromodulation
Interventions: Active tDCS + elbow flexion exercise, Sham tDCS + elbow flexion exercise; Device · Drug
Lead sponsor: Kessler Foundation; Other
Eligibility: 40 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Prostate Cancer
Interventions: dMD-002, Control; Device · Other
Lead sponsor: Mochida Medical USA, Inc.; Industry
Eligibility: 40 Years to 74 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity & Overweight, Prediabetes
Interventions: Precision Nutrition Intervention, Standard Nutrition Counseling; Behavioral
Lead sponsor: Prairie View A&M University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Prairie View, Texas

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: Palo Alto, California • Boston, Massachusetts

Conditions: Keratoconus
Interventions: Not listed
Lead sponsor: Power Life Sciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Therapeutic Plasma Exchange, Rituximab, Intravenous immunoglobulin, Treatment as Usual; Other · Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years to 85 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 9
States / cities: Birmingham, Alabama • Chicago, Illinois • Kansas City, Kansas + 4 more

Conditions: Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers, SARS CoV-2
Interventions: COMIRNATY®; Biological
Lead sponsor: PharmaJet, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Kidney Transplant Rejection
Interventions: Phenotypic Personalized Medicine Dosing, Standard of Care Dosing; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Renal Cell Carcinoma, Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Kidney Cancer
Interventions: Proteomic profiling of urinary EVs, Blood sample collection; Other · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Venus Leg Ulcers
Interventions: EscharEx (EX-03), Placebo (Gel vehicle), Non-surgical standard of care (NSSOC); Drug · Other
Lead sponsor: MediWound Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Maimi, Florida

Conditions: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, Multiple Myeloma
Interventions: LMY-922; Biological
Lead sponsor: Luminary Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Myelofibrosis
Interventions: Luspatercept, Pacritinib; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hepatic Cancer
Interventions: Seravue; Diagnostic Test
Lead sponsor: ImCare Biotech; Industry
Eligibility: 21 Years to 84 Years
Enrollment: 1,392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

CD34+ Transplants for Myeloid Malignancies

Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)

Cardiorespiratory Fitness and Acute High-Intensity Exercise Effects on Brain and Cognitive Function in Older Adults

"F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)

Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

Effects of Expectancy and Mindfulness Instructions on Chronic Pain

RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β

Zanzalintinib in Unresectable and Progressive MPGGs

Examining Analgesic Synergy and Efficacy in Trauma Care

tDCS for Cancer-Related Fatigue and Weakness

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported Communities

Phase 1: Thrive Together

Sonication-based OCD Neurosurgical Intervention Via Capsulotomy

Assessing Patient Engagement in Keratoconus Clinical Research

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to Non-surgical Standard of Care in Participants With Venous Leg Ulcers (VLU)

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

Study of LusPACercept in Participants With Myelofibrosis Associated Anemia and Thrombocytopenia

Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis